STOCK TITAN

CBDL's Recent Additions to Active Sales Channels Fuel 18-Month Sales Projections; CBD Vault(TM) Products' Projected 2025 Sales Revenues to Reach $1.8 Million

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Positive)
Tags

CBD Life Sciences Inc. (OTC PINK:CBDL) has announced an increased revenue projection for 2025, forecasting $1.8 million in sales for its CBD Vault™ brand. This upward revision is attributed to anticipated organic growth and expected revenue contributions from recently added sales channel partners. The company is also exploring opportunities to establish operating partnerships on a more national scale.

Lisa Nelson, CEO of CBDL, expressed satisfaction with the reception of the CBD Vault™ brand, noting its role in gaining traction and visibility in the competitive CBD products market. The company aims to leverage this increased visibility to secure stronger sales channel partners, which will drive future sales objectives.

Loading...
Loading translation...

Positive

  • Increased revenue projection for 2025 to $1.8 million
  • Recently launched CBD Vault™ brand gaining traction in the market
  • Addition of new sales channel partners
  • Exploring opportunities for national-scale operating partnerships

Negative

  • None.

News Market Reaction

-14.29%
1 alert
-14.29% News Effect

On the day this news was published, CBDL declined 14.29%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SCOTTSDALE, AZ / ACCESSWIRE / July 24, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), including its wholly-owned subsidiary, The CBD Vault Inc., a leading innovator in the CBD industry, has announced that it increased its revenue projection for 2025 to $1.8 million on the strength of its recently launched CBD VaultTM brand sales. The forecast increase is based both on anticipated organic growth and expected revenue contribution from recently added sales channel partners, as well as rapidly developing opportunities to establish operating partnerships on a more national scale.

"As we keep saying, we are extremely pleased with the reception of our CBD VaultTM brand in the way that it has gained us traction towards establishing greater visibility in the highly competitive CBD products market," said Lisa Nelson, CEO of CBDL. "We are committed to leveraging this greater visibility into ever-stronger sales channel partners that, in turn, will drive us to our future sales objectives."

About The CBD Vault Inc. and CBD Life Sciences, Inc.
The CBD Vault Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. The CBD Vault has developed and is retailing/wholesale a full line of cannabidiol based organic products including CBD Drops, Pain Relief Creams, Anxiety & Sleep Supplements, Edibles, Coffee, Skincare Line, Pet Line, Tablets. The CBD Vault's products can be viewed and purchased on the Company's website at www.thecbdvault.com

Follow our social media for the latest updates!

X: https://www.x.com/CBDL_StockOTC

Instagram: https://www.instagram.com/cbd.vault

IR Contact: cbdvaultaz@gmail.com

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences Inc.



View the original press release on accesswire.com

FAQ

What is CBD Life Sciences Inc.'s (CBDL) revenue projection for 2025?

CBD Life Sciences Inc. (CBDL) has increased its revenue projection for 2025 to $1.8 million, based on anticipated organic growth and expected revenue contributions from recently added sales channel partners.

What factors are contributing to CBDL's increased revenue projection?

CBDL's increased revenue projection is based on anticipated organic growth, expected revenue contributions from recently added sales channel partners, and opportunities to establish operating partnerships on a more national scale.

How is CBDL's CBD Vault™ brand performing in the market?

According to CBDL's CEO Lisa Nelson, the CBD Vault™ brand has been well-received and is gaining traction in the highly competitive CBD products market, helping to establish greater visibility for the company.

What is CBDL's strategy for achieving its future sales objectives?

CBDL aims to leverage the increased visibility gained from its CBD Vault™ brand to secure stronger sales channel partners, which will drive the company towards its future sales objectives.
Cbd Life Science

OTC:CBDL

CBDL Rankings

CBDL Latest News

CBDL Stock Data

1.30M
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Scottsdale